The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
We're proud to receive a 2025 CDMO Leadership Award in the “Small Molecule Dosage Form - Global" category.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
The journey to submitting an Investigational New Drug (IND) or Investigational Medicinal Product Dossier (IMPD) is a challenging endeavor, requiring drug developers to balance speed, risk, and future needs. To achieve a timely submission without compromising product quality or commercialization goals, a strategic and well-coordinated approach is essential.
Our infographic offers valuable insights and expert recommendations to expedite the IND/IMPD submission process. It outlines five key strategies to accelerate and optimize early drug development, ensuring that you stay ahead in the competitive pharmaceutical landscape.
In addition to these strategies, the infographic explores the pivotal role of partnering with a contract development and manufacturing organization (CDMO). By providing support in accelerating timelines, optimizing processes, and ensuring compliance with regulatory standards, CDMOs can enhance the overall success of your early development program.
Download the infographic to learn more.